drugset / Trial / NCT04616677
A Study to Evaluate the Effect of Renal Impairment on JNJ-42847922 in Adult Participants
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to evaluate the pharmacokinetic of a single oral dose of JNJ-42847922 in adult participants with renal impairment compared with healthy participants with normal renal function.
Timeline
- Start
- 2021-03-31
- Primary completion
- 2022-10-18
- Completion
- 2022-10-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Seltorexant | Small molecule | — | Oral |